BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 27623768)

  • 21. Low-density lipoprotein levels in patients with acute heart failure.
    Kahn MR; Kosmas CE; Wagman G; Serrao GW; Fallahi A; Grady KM; Vittorio TJ
    Congest Heart Fail; 2013; 19(2):85-91. PubMed ID: 23066917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Outcomes of Patients Treated With Pulmonary Vasodilators Early and in High Dose After Left Ventricular Assist Device Implantation.
    Critoph C; Green G; Hayes H; Baumwol J; Lam K; Larbalestier R; Chih S
    Artif Organs; 2016 Jan; 40(1):106-14. PubMed ID: 25994765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Ventricular Arrhythmia Ablation in Patients With Heart Mate II Left Ventricular Assist Devices: An Evaluation of Ablation Therapy.
    Snipelisky D; Reddy YN; Manocha K; Patel A; Dunlay SM; Friedman PA; Munger TM; Asirvatham SJ; Packer DL; Cha YM; Kapa S; Brady PA; Noseworthy PA; Maleszewski JJ; Mulpuru SK
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):68-77. PubMed ID: 27766717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation.
    Imamura T; Chung B; Nguyen A; Rodgers D; Sayer G; Adatya S; Sarswat N; Kim G; Raikhelkar J; Ota T; Song T; Juricek C; Kagan V; Jeevanandam V; Mehra M; Burkhoff D; Uriel N
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
    Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients.
    Brenyo A; Rao M; Koneru S; Hallinan W; Shah S; Massey HT; Chen L; Polonsky B; McNitt S; Huang DT; Goldenberg I; Aktas M
    J Cardiovasc Electrophysiol; 2012 May; 23(5):515-20. PubMed ID: 22081967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement?
    Mohamedali B; Yost G; Bhat G
    Tex Heart Inst J; 2017 Apr; 44(2):115-119. PubMed ID: 28461796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
    Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
    BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
    Demirozu ZT; Arat N; Kucukaksu DS
    Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation.
    Vest AR; Mistak SM; Hachamovitch R; Mountis MM; Moazami N; Young JB
    J Card Fail; 2016 Oct; 22(10):789-96. PubMed ID: 26924520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device Implantation.
    Majumder K; Spratt JR; Holley CT; Roy SS; Cogswell RJ; Liao K; John R
    Ann Thorac Surg; 2017 Nov; 104(5):1556-1562. PubMed ID: 28760474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure.
    Miller PE; Caraballo C; Ravindra NG; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Ali A; Desai NR; Ahmad T
    Circ Heart Fail; 2019 Nov; 12(11):e006369. PubMed ID: 31707800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.
    Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A
    Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation.
    Shiga T; Kinugawa K; Hatano M; Yao A; Nishimura T; Endo M; Kato N; Hirata Y; Kyo S; Ono M; Nagai R
    Circ J; 2011; 75(1):121-8. PubMed ID: 21116070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of pump replacement on outcome in advanced heart failure patients with left ventricular assist system.
    Iwashima Y; Yanase M; Horio T; Seguchi O; Murata Y; Fujita T; Toda K; Kawano Y; Nakatani T
    Artif Organs; 2013 Jul; 37(7):606-14. PubMed ID: 23692322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devices.
    Grosman-Rimon L; Jacobs I; Tumiati LC; McDonald MA; Bar-Ziv SP; Fuks A; Kawajiri H; Lazarte J; Ghashghai A; Shogilev DJ; Cherney DZ; Rao V
    Can J Cardiol; 2015 Mar; 31(3):348-56. PubMed ID: 25746024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices.
    Tomizawa Y; Tanaka A; Kitahara H; Sakuraba A; Uriel N; Jeevanandam V; Ota T
    Dig Dis Sci; 2018 Jun; 63(6):1518-1524. PubMed ID: 29417325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.